Home > Insider Trading > Filing (0001773751-25-000021)

Filing Details

Accession Number:: 0001773751-25-000021
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-01-23 16:32:41
Reporting Period:: 2025-01-21

Accepted Time:: 2025-01-23 16:32:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773751	Hims & Hers Health Inc.	HIMS	Services-Offices & Clinics Of Doctors Of Medicine (8011)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1837815	Melissa Baird	2269 Chestnut Street, #523 San Francisco CA 94123	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2025-01-21	67,687	$0.40	774,559	No	4	M	Direct
Class A Common Stock	Disposition	2025-01-21	4,195	$28.57	770,364	No	4	S	Direct
Class A Common Stock	Disposition	2025-01-21	13,430	$29.58	756,934	No	4	S	Direct
Class A Common Stock	Disposition	2025-01-21	9,280	$28.67	747,654	No	4	S	Direct
Class A Common Stock	Disposition	2025-01-21	31,845	$29.55	715,809	No	4	S	Direct
Class A Common Stock	Disposition	2025-01-21	4,461	$29.05	711,348	No	4	S	Direct
Class A Common Stock	Disposition	2025-01-21	4,476	$29.72	706,872	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (right to buy)	Disposition	2025-01-21	67,687	$0.00	67,687	$0.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
189,930		2028-03-28	No	4	M	Direct

Footnotes

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 30, 2024 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.025 - $28.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.00 - $29.95. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.20- $28.975. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.00 - $29.96. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.545 - $29.445. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.515- $29.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.